Farmacosmo S.p.A. (BIT:COSMO)
Italy · Delayed Price · Currency is EUR 0.4850
-0.0100 (-2.02%)
At close: Aug 14, 2026
Farmacosmo Revenue
In the year 2025, Farmacosmo had annual revenue of 52.46M EUR, down -17.64%. Farmacosmo had revenue of 24.43M in the half year ending December 31, 2025, a decrease of -30.54%.
Revenue (ttm)
52.70M
Revenue Growth
-17.60%
P/S Ratio
0.34
Revenue / Employee
645.22K
Employees
87
Market Cap
18.82M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.46M | -11.23M | -17.64% |
| Dec 31, 2024 | 63.70M | -8.91M | -12.27% |
| Dec 31, 2023 | 72.61M | 5.97M | 8.96% |
| Dec 31, 2022 | 66.64M | 8.14M | 13.92% |
| Dec 31, 2021 | 58.50M | 14.01M | 31.51% |
| Dec 31, 2020 | 44.48M | 20.17M | 82.96% |
| Dec 31, 2019 | 24.31M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.71B |
| Amplifon | 2.40B |
| DiaSorin | 1.18B |
| EL.En. | 595.51M |
| GPI S.p.A. | 546.18M |
| Svas Biosana | 141.56M |
| Talea Group | 132.17M |
| EuKedos | 52.91M |